{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-110848","form_type":"8-K","ticker":"CLRB","cik":"0001279704","company_name":"Cellectar Biosciences, Inc.","filed_at":"2025-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.020029+00:00","generated_at":"2026-05-16T20:09:25.454542+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cellectar Q3 net loss $4.4M ($1.41/sh); cash $12.6M; progress on EU conditional marketing for iopofosine","bullets":["Net loss narrowed to $4.4M ($1.41/sh) from $14.7M ($11.18/sh) YoY; R&D spending fell to $2.5M.","Cash $12.6M at Sep 30, plus $5.8M from Oct warrant exercises; runway into Q3 2026.","EMA SAWP confirmed iopofosine I 131 may qualify for Conditional Marketing Approval in WM; submission planned 2026.","Phase 1b of CLR 125 (Auger-emitter) for triple-negative breast cancer initiated; RPDD granted for iopofosine in pediatric high-grade glioma.","Raised ~$12.7M in Q3; funds to advance TNBC study and EMA application."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-110848","json":"https://secwatch.observer/filing/0001104659-25-110848.json","markdown":"https://secwatch.observer/filing/0001104659-25-110848.md","text":"https://secwatch.observer/filing/0001104659-25-110848.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925110848/0001104659-25-110848-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925110848/tm2531151d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:09:25.454542+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}